CHEMOBLAST is an antineoplastic medicine from the vinca alkaloid class. It disrupts cell division by inhibiting microtubule formation during mitosis.
Recommended for:
Hodgkin's lymphoma
Non-Hodgkin’s lymphoma
Breast cancer
Choriocarcinoma
Other malignancies sensitive to vinblastine
Used in the treatment of Hodgkin’s disease, non-Hodgkin’s lymphomas, choriocarcinoma, breast cancer, Kaposi’s sarcoma, multiple myeloma, and germ cell tumours.
Administered intravenously by a healthcare professional according to chemotherapy protocol. Dosage is individualised based on the patient’s diagnosis and condition.
Contraindications:
Hypersensitivity to vinblastine
Severe bone marrow suppression
Active infections
Pregnancy and lactation
Side Effects:
Bone marrow suppression
Nausea, vomiting
Hair loss
Peripheral neuropathy
Constipation
Fever